KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dorman Products (DORM) Accumulated Expenses (2016 - 2025)

Dorman Products (DORM) has 16 years of Accumulated Expenses data on record, last reported at $30.8 million in Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 30.1% year-over-year to $30.8 million; the TTM value through Dec 2025 reached $30.8 million, down 30.1%, while the annual FY2025 figure was $30.8 million, 30.1% down from the prior year.
  • Accumulated Expenses reached $30.8 million in Q4 2025 per DORM's latest filing, up from $25.5 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $44.0 million in Q4 2024 and bottomed at $12.6 million in Q2 2021.
  • Average Accumulated Expenses over 5 years is $21.1 million, with a median of $20.3 million recorded in 2021.
  • Peak YoY movement for Accumulated Expenses: soared 83.56% in 2024, then crashed 30.1% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $26.6 million in 2021, then fell by 26.83% to $19.5 million in 2022, then grew by 22.99% to $24.0 million in 2023, then skyrocketed by 83.56% to $44.0 million in 2024, then plummeted by 30.1% to $30.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $30.8 million in Q4 2025, $25.5 million in Q3 2025, and $24.1 million in Q2 2025.